HealthCentre Caps Trade Margins on Non-Scheduled Cancer Drugs at 30%
The central government has capped trade margins on non-scheduled anti-cancer medicines at 30% of their maximum retail price, aiming to reduce prices by up to 70%. This move is expected to save cancer patients ₹2,500 crore annually. The National Pharmaceutical Pricing Authority found some medicines had mark-ups as high as 700%. An expert committee will finalize the list of covered medicines.
Hindustan Times··New Delhi



